Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedJul 31, 2025
DataAggregated Company Financials
Companies54
  • 7D1.0%
  • 3M0.2%
  • 1Y-6.8%
  • YTD-17.0%

In the last week, the Biotech industry is flat overall, with BioArctic standing out by going down 4.7%. As for the longer term, the industry has declined 6.8% in the last year. Looking forward, earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 01 Aug 2025SEK 191.1bSEK 35.9bSEK 2.8b28.3x68.5x5.3x
Sun, 29 Jun 2025SEK 185.5bSEK 35.2bSEK 2.2b29.4x83.4x5.3x
Tue, 27 May 2025SEK 188.1bSEK 35.2bSEK 2.2b29.9x86.3x5.3x
Thu, 24 Apr 2025SEK 183.7bSEK 33.7bSEK 757.9m29.3x242.4x5.5x
Sat, 22 Mar 2025SEK 193.8bSEK 33.7bSEK 723.4m33.1x267.9x5.8x
Mon, 17 Feb 2025SEK 207.7bSEK 33.3bSEK 346.3m45.7x599.9x6.2x
Wed, 15 Jan 2025SEK 216.0bSEK 33.0b-SEK 4,402,338,767.02150.8x-49.1x6.5x
Fri, 13 Dec 2024SEK 212.1bSEK 33.0b-SEK 4,445,656,495.28141.9x-47.7x6.4x
Sun, 10 Nov 2024SEK 214.4bSEK 33.2b-SEK 4,187,800,234.70146.7x-51.2x6.5x
Tue, 08 Oct 2024SEK 207.6bSEK 31.4b-SEK 5,523,799,556.3848.8x-37.6x6.6x
Thu, 05 Sep 2024SEK 212.5bSEK 31.5b-SEK 5,518,282,956.0249.4x-38.5x6.8x
Sat, 03 Aug 2024SEK 194.1bSEK 31.4b-SEK 5,420,171,537.8743.2x-35.8x6.2x
Mon, 01 Jul 2024SEK 196.6bSEK 30.6b-SEK 5,537,729,202.1039.3x-35.5x6.4x
Wed, 29 May 2024SEK 191.1bSEK 30.6b-SEK 5,400,007,476.4439.1x-35.4x6.2x
Fri, 26 Apr 2024SEK 182.4bSEK 30.8b-SEK 5,554,927,800.4354.1x-32.8x5.9x
Sun, 24 Mar 2024SEK 184.6bSEK 29.8b-SEK 5,636,766,957.1158.7x-32.8x6.2x
Tue, 20 Feb 2024SEK 179.6bSEK 29.7b-SEK 5,699,202,242.0650.5x-31.5x6x
Thu, 18 Jan 2024SEK 186.9bSEK 28.7b-SEK 1,200,066,697.0059x-155.7x6.5x
Sat, 16 Dec 2023SEK 196.9bSEK 28.7b-SEK 1,170,293,890.0060.4x-168.2x6.9x
Mon, 13 Nov 2023SEK 160.8bSEK 28.7b-SEK 1,239,683,686.0050.6x-129.7x5.6x
Wed, 11 Oct 2023SEK 158.8bSEK 27.4b-SEK 2,015,877,318.0049x-78.8x5.8x
Fri, 08 Sep 2023SEK 151.3bSEK 27.4b-SEK 1,977,647,867.0047.9x-76.5x5.5x
Sun, 06 Aug 2023SEK 153.8bSEK 27.5b-SEK 1,574,427,530.0054.3x-97.7x5.6x
Tue, 04 Jul 2023SEK 160.1bSEK 26.4b-SEK 1,318,226,622.0044.8x-121.5x6.1x
Thu, 01 Jun 2023SEK 166.0bSEK 26.3b-SEK 1,209,449,751.0044x-137.2x6.3x
Sat, 29 Apr 2023SEK 175.8bSEK 26.3b-SEK 1,265,095,929.0045.6x-139x6.7x
Mon, 27 Mar 2023SEK 165.5bSEK 25.4b-SEK 2,031,671,425.0039.2x-81.5x6.5x
Wed, 22 Feb 2023SEK 171.3bSEK 25.4b-SEK 2,097,874,722.0037.8x-81.7x6.8x
Fri, 20 Jan 2023SEK 176.0bSEK 23.8b-SEK 1,843,117,918.0032.1x-95.5x7.4x
Sun, 18 Dec 2022SEK 158.6bSEK 23.8b-SEK 1,838,013,390.0031.2x-86.3x6.7x
Tue, 15 Nov 2022SEK 158.6bSEK 23.9b-SEK 1,905,469,956.0032.2x-83.2x6.6x
Thu, 13 Oct 2022SEK 151.2bSEK 22.9b-SEK 3,333,482,070.0031x-45.4x6.6x
Sat, 10 Sep 2022SEK 159.5bSEK 22.9b-SEK 3,243,830,491.0034x-49.2x7x
Mon, 08 Aug 2022SEK 169.8bSEK 22.7b-SEK 3,502,700,170.0035.8x-48.5x7.5x
Price to Earnings Ratio

-48.5x


Total Market Cap: SEK 169.8bTotal Earnings: -SEK 3,502,700,170.00Total Revenue: SEK 22.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -39.9x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 68.5x which is higher than its 3-year average PE of -40.0x.
  • The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.28%
Healthcare0.88%
Biotech0.97%
Biotech0.97%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BONEX Bonesupport HoldingSEK 330.602.9%
+SEK 605.9m		14.8%PE147.1x
ONCO OncopeptidesSEK 6.1526.8%
+SEK 293.5m		154.1%PS34.8x
HNSA Hansa BiopharmaSEK 28.787.1%
+SEK 162.7m		-28.0%PS12.4x
VICO Vicore Pharma HoldingSEK 9.165.8%
+SEK 117.3m		-48.8%PS358.5x
ISOFOL Isofol MedicalSEK 0.91-6.1%
SEK 99.0m		-63.2%PB4x

Latest News

ISOFOL
SEK 0.91
Isofol Medical
7D
-6.1%
1Y
-63.2%
BONEX
SEK 330.60
Bonesupport Holding
7D
2.9%
1Y
14.8%
HNSA
SEK 28.78
Hansa Biopharma
7D
7.1%
1Y
-28.0%
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%
VITR
SEK 144.00
Vitrolife
7D
-2.2%
1Y
-37.7%
author-image

US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery

Recovery in IVF procedure volume and expansion in key regions will drive organic revenue growth and margin improvement as market conditions stabilize.
ONCO
SEK 6.15
Oncopeptides
7D
26.8%
1Y
154.1%

A Look At The Fair Value Of Oncopeptides AB (publ) (STO:ONCO)

Jul 28
A Look At The Fair Value Of Oncopeptides AB (publ) (STO:ONCO)
SOBI
SEK 269.60
Swedish Orphan Biovitrum
7D
-4.5%
1Y
-3.0%
BIOG B
SEK 98.50
BioGaia
7D
-1.4%
1Y
-22.3%
BIOA B
SEK 215.40
BioArctic
7D
-1.9%
1Y
29.4%
EGTX
SEK 5.51
Egetis Therapeutics
7D
-9.7%
1Y
-6.1%
CRNO B
SEK 9.29
Cereno Scientific
7D
-8.4%
1Y
60.2%
SYNACT
SEK 22.10
SynAct Pharma
7D
8.9%
1Y
142.9%
DMYD B
SEK 10.88
Diamyd Medical
7D
-4.7%
1Y
-41.6%
SANION
SEK 9.57
Saniona
7D
5.9%
1Y
95.3%

Improved Revenues Required Before Saniona AB (publ) (STO:SANION) Stock's 37% Jump Looks Justified

Jun 19
Improved Revenues Required Before Saniona AB (publ) (STO:SANION) Stock's 37% Jump Looks Justified
BINV
SEK 38.90
BioInvent International
7D
-3.6%
1Y
-4.1%
VICO
SEK 9.16
Vicore Pharma Holding
7D
5.8%
1Y
-48.8%